A global survey of 231 labs in 41 countries, published by IOF and IFCC, reveals significant inconsistencies in bone biomarker testing methods, reference intervals, and quality assessments, highlighting a need for greater harmonization.
Siemens Healthineers and Novo announced a collaboration to expand clinical access to non-invasive blood tests, including the ELF test, for earlier detection of MASLD and MASH.
ADLM 2026 drew nearly 17,000 professionals to Anaheim, where experts discussed advances in space diagnostics, mass spectrometry, and chronic disease management, and Kompass Diagnostics won the Disruptive Technology Award for its IDA platform.
Ataraxis AI’s laboratory has received CAP accreditation and a California clinical lab license, expanding clinician access to its AI-powered breast cancer platform.
A new SHEA framework outlines how targeted diagnostic stewardship interventions could save a 200-bed hospital up to $2.8 million annually.
Lot-to-lot reagent inconsistencies can have significant effects on patient test results.
The rollout links more than 350 pathology experts across 12 countries to support routine case review and AI diagnostic integration.
Urinalysis comparison guide featuring testing capabilities, technology, throughput, connectivity, sample capacity, and key specifications from leading systems.